Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03563287Completed
Open-label trial of melatonin, nicotine, bupropion, repaglinide, losartan and 4 more, sponsored by University of Eastern Finland. Started Jan 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03563287.